pharma-tech
(3)
Jack Porter
Jack Porter is a serial entrepreneur, multi-time CEO, and co-founder of Cognizer Inc, an AI-powered contract intelligence company based in Pleasanton, California. With a career spanning decades and leadership of more than seven software companies, Porter has worked on AI projects for clients including American Express, Discover Card, Merck, and GlaxoSmithKline. At Cognizer, he is building a platform that uses knowledge graphs, graph neural networks, and large language models to help enterprise legal, sales, and procurement teams extract intelligence from contracts at scale. Cognizer has raised over $16M in funding and is recognized for its Genius AI platform, which achieves 97% accuracy in extracting contract terms and clauses.
Tom Lemberg
Tom Lemberg is the Founder & CEO of Curebase, a San Francisco-based decentralized clinical trial platform that has enrolled over 60,000 patients across 60+ studies. A Harvard-trained computer scientist and molecular biologist, Lemberg built Curebase from his couch in 2017, joined Y Combinator in 2018, and raised $59M to transform how clinical trials work - letting patients participate from home and bringing their own doctors into the research process. Named to Forbes 30 Under 30 in 2022, he's on a mission to make clinical trials accessible to any patient, anywhere.
Levi Malott
Levi Malott is a Missouri-native software engineer turned startup operator and venture capitalist who tested Falcon 9 rocket systems at SpaceX, built ML infrastructure at BetterUp, scaled Pachama's engineering team from 7 to 40 people as VP of Engineering through a $700M valuation, then co-founded Weave Bio as CTO - an AI platform accelerating pharmaceutical regulatory filings that raised a $10M seed round in 2023. Today he serves as Venture Partner at Redbud VC in Columbia, Missouri, backing early-stage tech founders from the heartland.